Concepedia

Sibu Kuruvilla

SK

Statistics

Publications

9

Citations

406

H-Index

9

Active since

2013

Affiliations

University of Michigan(Current)

Stanford University

NYU Langone Health

Sibu Kuruvilla is an author at University of Michigan specializing in oncology, drug delivery, and pharmacy.

ORCID

Publications per year

2013–2022

9

Publications

9

Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells

Scott H. Medina, Maxim V. Chevliakov, Gopinath Tiruchinapally et al. · Biomaterials · 2013 · 90 citations

, , +16

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity

Renumathy Dhanasekaran, Virginie Baylot, Minsoon Kim et al. · eLife · 2020 · 73 citations · Full text

, , +17

MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages

Renumathy Dhanasekaran, Aida S. Hansen, Jangho Park et al. · Cancer Research · 2022 · 56 citations · Full text

, , +17

Anti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy

Christina K. Lee, Danielle F. Atibalentja, Lilian Yao et al. · Nanotheranostics · 2022 · 50 citations · Full text

, , +17

Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model

Sibu Kuruvilla, Gopinath Tiruchinapally, A. Colleen Crouch et al. · PLoS ONE · 2017 · 42 citations · Full text

, , +17

1–5 of 9